Two new nucleotide antibiotics, named sinefungin VA and dehydrosinefungin V, were separated by cation exchange column chromatography and purified by HPLC from the culture broth of Streptomyces sp. K05-0178, together with the known antibiotics, sinefungin, dehydrosinefungin and KSA-9342. The structures of the two novel sinefungin analogs were elucidated by spectroscopic studies, including various NMR and advanced peptide chemical methods. Sinefungin VA consists of adenosine and ornithylvalylalanine, whereas dehydrosinefungin V consists of 4¢,5¢-dehydroadenosine and ornithylvaline. Sinefungin VA showed potent antitrypanosomal activity with an IC 50 value of 0.0026 lg ml À1 in vitro without cytotoxicity against MRC-5 cells. Dehydrosinefungin V showed moderate antitrypanosomal activity (IC 50 ¼0.15 lg ml À1 ).
INTRODUCTION
Human African trypanosomiasis, also known as sleeping sickness, is regarded as one of the major neglected tropical diseases. It is a complex disease caused by infection with protozoan Trypanosoma spp. parasites, transmitted through the bites of infected tsetse flies. There are two forms of the disease, each having two distinct stages, and without treatment the disease is fatal. Today, some 70 million people are exposed to the threat of human African trypanosomiasis. 1 It was estimated that, in 2004, approximately 50 000-70 000 new cases of human African trypanosomiasis were occurring annually. 1 Currently, only four drugs, pentamidine, suramin, melarsoprol and eflornithine, are registered for the treatment of human African trypanosomiasis. All four are unsatisfactory, as they cannot be administered orally and are hampered by severe toxicity and increasing resistance of the parasites. Although there is a clear and urgent need for new classes of antitrypanosomal compounds, and despite the recent introduction of a new treatment using a combination of two existing drugs, no effective new drugs have been introduced into the field for 20 years.
During our screening program to discover new antitrypanosomal antibiotics, two novel sinefungin analogs, sinefungin VA (1) and dehydrosinefungin V (2), and three recognized structurally related compounds, sinefungin (3), dehydrosinefungin (4) and KSA-9342 (5), were isolated from a culture broth of Streptomyces sp. K05-0178 ( Figure 1 ). In this paper, the fermentation, isolation, physicochemical properties and structure elucidation and biological properties of 1 and 2 are described.
RESULTS

Taxonomy of the producing strain K05-0178
The strain K05-0178 was isolated from a soil sample collected at Minato-ku, Tokyo, Japan. The vegetative mycelia developed well on yeast extract-malt extract agar, oatmeal agar and inorganic saltsstarch agar and did not show fragmentation into coccoid forms or bacillary elements. The color of vegetative mycelia showed red. Aerial mycelia were produced abundantly on inorganic salts-starch agar and the aerial mass color showed pink. The strain formed verticillate sporophores bearing terminal umbels of spore chains (Figure 2 ). The mature spore chain had 5-10 spores per chain. The spores were cylindrical in shape, 1.0Â0.5 mm in size and had a smooth surface. Brownish soluble pigment was produced on yeast extract-malt extract agar. The isomer of diaminopimelic acid in whole-cell hydrolysates of strain K05-0178 was determined to be the LL-form. An almost complete 16S rDNA sequence (1400 nucleotides) was determined, and the result of the identification analysis by EzTaxon.org server version 2.1 (http://147.47.212.35:8080/) showed the highest similarity value with Streptomyces coerulescens NBRC 12758 T (AB184122, 99.6%) and Streptomyces abikoensis NBRC 13860 T (AB184537, 99.6%). On the basis of the morphological and cultural properties and 16S rDNA sequence similarity, the strain was identified with whorl-forming Streptomyces species and designated Streptomyces sp. K05-0178. 2, 3 Isolation The procedure for isolation of sinefungin analogs is summarized in Scheme 1. The 6-day-old culture broth (10 l) was extracted with 10 l of ethanol and filtered through a paper to separate into supernatant and mycelia. The supernatant was concentrated under reduced pressure to remove ethanol and then passed through a Dowex 50 WÂ2 [H + ] column (50 i.d. Â400 mm, Dow Chemical, Midland, MI, USA) previously activated. After washing with water (600 ml), the active materials were eluted with 1.0 M NH 4 OH (600 ml), followed by neutralization by HCl and desalted by a Micro Acylizer S3 (ASTOM, Tokyo, Japan). The whole eluate was applied on a Toyopearl SP-650C column (3.0 i.d. Â300 mm, Tosoh Co., Tokyo, Japan) previously equilibrated with 0.1 M CH 3 COONH 4 buffer (pH 3.8).
After washing with 0.1 M CH 3 COONH 4 buffer (pH 3.8, 180 ml), the active materials were eluted with 0.2, 0.4 and 0.6 M CH 3 COONH 4 buffers (pH 3.8, 180 ml each). The 0.4 and 0.6 M CH 3 COONH 4 fractions were neutralized by NH 4 OH, desalted by the Micro Acylizer and concentrated in vacuo to dryness to yield a brown material (1143 mg). The material was dissolved in a small amount of water and purified by HPLC on an XBridge Shield RP18 column (10 i.d. Â250 mm, Waters Milford, MA, USA) with 1.5% CH 3 CN/10 mM CH 3 COONH 4 (pH 10) at 4.0 ml min À1 detected at UV 210 nm. The retention times of sinefungin VA (1), dehydrosinefungin V (2) and KSA-9342 (5) were 33, 42 and 55 min, respectively (Figure 3a) . Each solution was neutralized by HCl, desalted by Sephadex G-10 (GE Healthcare, Buckinghamshire, UK) gel filtration chromatography and concentrated in vacuo to dryness to afford 1 (0.2 mg), 2 (29 mg) and 5 (49 mg) as pale brown powders. On the other hand, the 0.2 M CH 3 COONH 4 fraction was neutralized, desalted by the Micro Acylizer and concentrated in vacuo to dryness to yield a brown material (438 mg). It was dissolved in a small amount of water and purified by HPLC on an XBridge Shield RP18 column (10 i.d. Â250 mm) with 0.5% CH 3 CN/10 mM CH 3 COONH 4 (pH 10) at 4.0 ml min À1 detected at UV 210 nm. The retention times of sinefungin (3) and dehydrosinefungin (4) were 9 and 13 min, respectively (Figure 3b ). Each solution was neutralized by HCl, desalted by the Micro Acylizer and concentrated in vacuo to dryness to afford 3 (73 mg) and 4 (60 mg) as pale brown powders.
Physicochemical properties
The physicochemical properties of sinefungin VA (1) and dehydrosinefungin V (2) are summarized in Table 1 . They are both readily soluble in water, methanol and acetone. They showed absorption maxima at 206 and 260 nm in UV spectra. The broad IR absorption at 3300 cm À1 suggested the presence of hydroxyl groups. The similarity in physicochemical properties strongly suggested that they are structurally related to sinefungin (3).
Identification of sinefungins, dehydrosinefungin and KSA-9342
The molecular formulae of 3-5 were elucidated by HR-FAB-MS to be C 15 Table 1 ). The analysis of 1 H, 13 C and 2D NMR spectra data led to the identification of 3-5 as sinefungin, 4 dehydrosinefungin 5 and KSA-9342, 6 respectively. As the assignments of their chemical shifts have not been reported, the data are shown in Table 2 . Table 2 . The 13 C NMR and heteronuclear multiple quantum coherence (HMQC) spectra indicated 23 carbons, which were classified into one carboxyl carbon at d c 181.3, two amide carbonyl carbons, five olefinic carbons, one hemiaminal carbon at d c 88.8, three oxygenated sp 3 methine carbons, four nitrogenated sp 3 methine carbons, one sp 3 methine carbon, three sp 3 methylene carbons and three methyl carbons. The characteristic UV spectra and fragment ion (m/z 135) in FAB-MS indicated the presence of an adenine moiety. Moreover, the spin systems from H-2 to H-10, deduced by the COSY, and the correlations from H-2 to C-1 and C-3, from H-5 to C-7, from H-8 and H-9 to C-10, and from H-10 to C-11 and C-15 of the adenine moiety in the heteronuclear multiple-bond correlation (HMBC) spectra, revealed 1 was a sinefungin analog ( Figure 4 ). This was confirmed by comparison with the NMR spectra of sinefungin ( Table 2 ). The spin systems from H-2¢ to H 3 -5¢ and from H-2 00 to H 3 -3 00 by the COSY and the correlations from H-2¢ and H-2 The absolute configurations of amino acid residues of 1 were elucidated to be L-Val and L-Ala by HPLC analysis of the hydrolysates of 1 using a chiral column. Thus, the structure of 1 is shown in Figure 1 , and the compound was designated as sinefungin VA.
Structure elucidation of dehydrosinefungin V (2)
The molecular formula of 2 was elucidated by HR-FAB-MS to be C 20 H 30 N 8 O 6 , requiring 10 degrees of unsaturation. The 1 H and 13 C NMR spectral data of 2 are listed in New antitrypanosomal sinefungin VA and dehydrosinefungin V M Niitsuma et al characteristic UV spectrum and fragment ion (m/z 135) in FAB mass spectrum indicated the presence of an adenine moiety. Moreover, the spin systems from H-2 to H-6 and from H-8 to H-10, deduced by the 1 H-1 H COSY, and the correlations from H-2 to C-1 and C-3, from H-6 to C-7 and C-8, from H-8 to C-10 and from H-10 to C-11 and C-15 of the adenine moiety in the HMBC spectra, revealed that 2 was a dehydrosinefungin analog ( Figure 4 ). This was confirmed by comparison with the NMR spectra of dehydrosinefungin ( Table 2 ). The spin systems from H-2¢ to H 3 -5¢ by the COSY and the correlations from H-2¢ to C-1¢ in the HMBC spectra indicated the presence of a valyl moiety. The correlations from H-2¢ to C-1 in HMBC revealed the C-1 of dehydrosinefungin was attached to the amino group of the valyl moiety to form an amide bond. The absolute configuration of the valine residue was determined to be the L-form by HPLC analysis of the hydrolysates of 2 using a chiral column. The structure of 2 is shown in Figure 1 , and the compound was designated as dehydrosinefungin V.
Biological activities
As shown in Table 3 , sinefungin VA (1) showed potent activity against Trypanosoma brucei brucei GUTat 3.1 strain with an IC 50 value of 2.60Â10 À3 mg ml À1 , which was 10-fold less than that of sinefungin (IC 50 value of 2.10Â10 À4 mg ml À1 ) but approximately 600-fold higher than that of the commonly used therapeutic drug, suramin.
However, 1 exhibited significantly less cytotoxicity against MRC-5 cells than sinefungin. Dehydrosinefungin V (2) showed moderate antitrypanosomal activity with IC 50 values of 0.14 mg ml À1 , which was similar to that of dehydrosinefungin (4) and KSA-9342 (5).
A selectivity index (see Table 3 ), created to allow direct comparisons of effectiveness and cytotoxicity, indicated that sinefungin VA was almost 200-fold less potent than sinefungin but that, significantly, it was some 30-fold better than suramin.
DISCUSSION
Sinefungin and its analog, dehydrosinefungin, were isolated from a culture broth of Streptomyces griseolus and found to have antifungal and antitrypanosomal properties. 4, 5 Sinefungin is a nucleoside antibiotic containing an ornithine residue linked by a C-C bond to the 5¢ carbon of adenosine. The biosynthetic precursors of sinefungin were reported as being L-arginine and ATP, using incorporation studies as well as HPLC analysis, 7 although the details remain unclear. The isolation of sinefungin and its various analogs from the same culture broth in this study might provide a clue to help solve their biosynthesis pathway. Sinefungin is a structural analog of S-adenosylmethionine, a molecule that has an important role in the biosynthesis of polyamines and in transmethylations of proteins and lipids. Sinefungin and dehydrosinefungin are very potent inhibitors of S-adenosylmethionine-dependent transmethylations. 8 Sinefungin was also reported to exhibit strong antiviral, antileishmanial and antitumor activity. [8] [9] [10] In our study, compounds having a single bond between C-6 and C-7 of adenosine (sinefungin and sinefungin VA) showed potent antitrypanosomal activity as compared with compounds having a double bond (dehydrosinefungin, dehydrosinefungin V and KSA-9342). Many biological activities of sinefungin are believed to be related to the inhibition of S-adenosylmethionine-dependent methyltransferase enzymes. [11] [12] [13] [14] [15] [16] When administered intraperitoneally, sinefungin cures mice infected with T. brucei brucei, Trypanosoma congolense and Trypanosoma vivax. 17, 18 It was well tolerated in mice, and when the dose per injection was 0.05-5 mg kg À1 , sinefungin was highly effective against African trypanosomes. Sinefungin and dehydrosinefungin were also leishmanicidal at concentrations ranging from 0.13 to 2.6 mM in vitro. 9 Our data confirm that sinefungin is both a potent antitrypanosomal and that it has a moderate cytotoxic effect against MRC-5 cells. Hitherto, sinefungin has not been developed because of its serious side effects (nephrotoxicity at subcurative levels in goats and dogs and toxicity for bone marrow cells). 19, 20 However, synthetic studies for New antitrypanosomal sinefungin VA and dehydrosinefungin V M Niitsuma et al some analogs have been reported to improve the therapeutic index. 21, 22 Our results indicate that sinefungin VA retains potent antitrypanosomal properties but with a greatly reduced cytotoxicity, significantly outperforming suramin, indicating that it could be a promising candidate for development into a novel new antitrypanosomal drug.
METHODS
Taxonomic studies
We observed cultural and physiological characteristics of strain K05-0178 grown on yeast extract-malt extract agar, oatmeal agar and inorganic saltsstarch agar, after incubation for 2 weeks at 27 1C. The morphological properties were observed with a scanning electron microscope (model JSM-5600, JEOL, Akishima, Japan) after cultivation on 1/10 V8 juice agar at 27 1C for 18 days. Isomers of diaminopimelic acid in whole-cell hydrolysates were determined by TLC, following the standard methods of Becker et al. 23 and Hasegawa et al. 24 16S rDNA was amplified by PCR and sequenced directly on an ABI model 377A automatic DNA sequencer using a PRISM Ready Reaction Dye Primer Cycle Sequencing Kit (Applied Biosystems, Carlsbad, CA, USA).
Fermentation
The strain K05-0178 was grown and maintained on agar slants consisting of 1.0% starch, 0.3% NZ amine, 0.1% yeast extract, 0.1% meat extract, 1.2% agar and 0.3% CaCO 3 . A loop of spores of strain K05-0178 was inoculated into 100 ml of seed medium, consisting of 2.4% starch, 0.1% glucose, 0.3% peptone, 0.3% meat extract, 0.5% yeast extract and 0.4% CaCO 3 (adjusted to pH 7.0 before sterilization) in a 500-ml Erlenmeyer flask. The flask was incubated on a rotary shaker (210 r.p.m.) at 27 1C for 3 days. A 1 ml portion of the seed culture was transferred to 500-ml Erlenmeyer flasks (total 100) containing 100 ml of production medium, consisting of 0.5% glucose, 0.5% corn steep powder, 
Amino acid analysis
Each of 1-3 (100 mg) was completely hydrolyzed in a gas phase of 6 M HCl (100 ml) at 110 1C for 18 h in a reaction vial in which air was replaced by N 2 gas, using the Pico-Tag work station (Waters). For elucidation of the absolute configuration of amino acids, the hydrolysates were dissolved in distilled water and subjected to HPLC analysis (Column, Sumichiral OA-5000 (4.6 i.d. 
Antitrypanosomal activity in vitro
In vitro antitrypanosomal activities against T. brucei brucei strain GUTat 3.1 were measured, using the method described previously. 25 In brief, the strain GUTat 3.1 was cultured in Iscove's modified Dulbecco's medium (IMDM) with various supplements and 10% heat-inactivated fetal bovine serum at 37 1C, under 5.0% CO 2 /95% air. Subsequently, 95 ml of the trypanosomes suspension (2.0-2.5Â10 4 trypanosomes ml À1 ) was transferred in a 96-well microtiter plate and 5.0 ml of a test compound solution (dissolved in 5.0% DMSO) was added and incubated for 72 h at 37 1C (long incubation-low inoculation test). After that, 10 ml of the fluorescent dye alamer blue was added to each well. After incubation for 3-6 h, the resulting solution was read at 528/20 nm excitation wavelengths and 590/ 30 nm emission wavelengths by an FLx800 fluorescence microplate reader (BioTek Instruments, Winooski, VT, USA). The IC 50 values were determined using the fluorescent plate reader software (KC-4, BioTek). Successive subcultures were done in 24-well tissue culture plates under the same conditions.
Cytotoxic activity in vitro
Measurement of cytotoxic activity against human fetal lung fibroblast MRC-5 cells was carried out as described previously. 26 
